Volume 9 (2011): Issue 8 (Aug 2011)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xix–xxi
Oncology Research Program
Pages: xxx–xxxi
Crescendos and Decrescendos: Gastric and Esophageal Cancers
By: Jaffer A. Ajani
Pages: 811–813
Drug Shortages: Impact and Strategies
By: Philip E. Johnson
Pages: 815–819
Proton Therapy in an Era of Cost Containment
By: Joseph M. Herman
Pages: 821–825
Esophageal and Esophagogastric Junction Cancers
By: Jaffer A. Ajani, James S. Barthel, David J. Bentrem, Thomas A. D'Amico, Prajnan Das, Crystal S. Denlinger, Charles S. Fuchs, Hans Gerdes, Robert E. Glasgow, James A. Hayman, Wayne L. Hofstetter, David H. Ilson, Rajesh N. Keswani, Lawrence R. Kleinberg, W. Michael Korn, A. Craig Lockhart, Mary F. Mulcahy, Mark B. Orringer, Raymond U. Osarogiagbon, James A. Posey, Aaron R. Sasson, Walter J. Scott, Stephen Shibata, Vivian E. M. Strong, Thomas K. Varghese Jr., Graham Warren, Mary Kay Washington, Christopher Willett, and Cameron D. Wright
Pages: 830–887
Endoscopic Therapy of Esophageal Premalignancy and Early Malignancy
By: Thomas B. Nealis, Kay Washington, and Rajesh N. Keswani
Pages: 890–899
Modern Approaches to Localized Cancer of the Esophagus
By: Robert E. Glasgow, David H. Ilson, James A. Hayman, Hans Gerdes, Mary F. Mulcahy, and Jaffer A. Ajani
Pages: 902–911
Myeloid Growth Factors
By: Jeffrey Crawford, Jeffrey Allen, James Armitage, Douglas W. Blayney, Spero R. Cataland, Mark L. Heaney, Sally Htoy, Susan Hudock, Dwight D. Kloth, David J. Kuter, Gary H. Lyman, Brandon McMahon, David P. Steensma, Saroj Vadhan-Raj, Peter Westervelt, and Michael Westmoreland
Pages: 914–932
Biosimilars: Are They Ready for Primetime in the United States?
By: Bradford R. Hirsch and Gary H. Lyman
Pages: 934–943
Long-Term Outcomes of Myeloid Growth Factor Treatment
By: Gary H. Lyman and David C. Dale
Pages: 945–952
  • Collapse
  • Expand